Key facts
- This page summarizes Gregory Vizirgianakis's Form 3 filing for Medinotec Inc. (MDNC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2025, 12:23.
Gregory Vizirgianakis - 16 Apr 2025 Form 3 Insider Report for Medinotec Inc. (MDNC)
- Reporting relationship
- President, Secretary, CEO, Director, 10%+ Owner
- Issuer ticker
- MDNC
- Reported as of
- 16 Apr 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Gregory Vizirgianakis
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Gregory Vizirgianakis filed Form 3 for Medinotec Inc. (MDNC) on 12 Jun 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002071168
Primary reporting owner
Vizirgianakis Gregory
- Relationship
- President, Secretary, CEO, Director, 10%+ Owner
- Address
- 10 NEW MARKET RD, NORTHRIDING RANDBURG, JOHANNESBURG, SOUTH AFRICA
- Signature
- /s/ Gregory Vizirgianakis
- Signature date
- 12 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDNC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,750,179
- Date
- 16 Apr 2025
- Ownership
- Medisol Pty Ltd
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes 4,750,179 shares held in Medisol Pty Ltd, in which Mr. Vizirgianakis has voting and investment control.